FAM83B, A NOVEL MOLECULAR TARGET FOR LUNG SQUAMOUS CELL CARCINOMA.

被引:0
|
作者
Okabe, Naoyuki [1 ]
Suzuki, Hiroyuki [1 ]
Higuchi, Mitsunori [1 ]
Osugi, Jun [1 ]
Hasegawa, Takeo [1 ]
Yaginuma, Hiroshi [1 ]
Muto, Satoshi [1 ]
Yamaura, Takumi [1 ]
Watanabe, Yuzuru [1 ]
Owada, Yuki [1 ]
Watanabe, Shinya [2 ]
Waguri, Satoshi [2 ]
Ezaki, Jyunji [2 ]
机构
[1] Fukushima Med Univ, Dept Thorac Surg, Fukushima, Japan
[2] Fukushima Med Univ, Translat Res Ctr, Fukushima, Japan
关键词
FAM83B; SCC; lung squamous cell carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S484 / S485
页数:2
相关论文
共 50 条
  • [21] Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma
    Fei Li
    Zhaoyuan Fang
    Jian Zhang
    Chen Li
    Hongyan Liu
    Jufeng Xia
    Hongwen Zhu
    Chenchen Guo
    Zhen Qin
    Fuming Li
    Xiangkun Han
    Yuetong Wang
    Yan Feng
    Ye Wang
    Wenjing Zhang
    Zuoyun Wang
    Yujuan Jin
    Yihua Sun
    Wenyi Wei
    Rong Zeng
    Haiquan Chen
    Hongbin Ji
    Cell Research, 2016, 26 : 1149 - 1164
  • [22] Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma
    Li, Fei
    Fang, Zhaoyuan
    Zhang, Jian
    Li, Chen
    Liu, Hongyan
    Xia, Jufeng
    Zhu, Hongwen
    Guo, Chenchen
    Qin, Zhen
    Li, Fuming
    Han, Xiangkun
    Wang, Yuetong
    Feng, Yan
    Wang, Ye
    Zhang, Wenjing
    Wang, Zuoyun
    Jin, Yujuan
    Sun, Yihua
    Wei, Wenyi
    Zeng, Rong
    Chen, Haiquan
    Ji, Hongbin
    CELL RESEARCH, 2016, 26 (10) : 1149 - 1164
  • [23] Synchronous primary lung sarcomatous carcinoma and lung squamous cell carcinoma: a case report
    Zhao, Maoyuan
    Jing, Qiuyang
    Hui, Zhouguang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (03): : 480 - 483
  • [24] Landscape of targeted therapies for lung squamous cell carcinoma
    Chen, Qiuxuan
    Zheng, Xiaoshuo
    Cheng, Weiting
    Li, Jian
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [25] Testicular metastasis from squamous cell carcinoma of the lung
    Uchida, K
    Kurimura, Y
    Miyake, M
    Ando, M
    Tanaka, T
    Sasao, T
    Sano, M
    Yoshioka, M
    Yamaguchi, Y
    INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (06) : 350 - 352
  • [26] Genomic Correlates with Ancestry in Lung Squamous Cell Carcinoma
    Jain, S.
    Yao, A.
    Allen-Gipson, D.
    Momen-Heravi, F.
    Zhang, X.
    Carrot-Zhang, J.
    Taylor, A. M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S430 - S431
  • [27] A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells
    Liu, Yuan-Yuan
    Ding, Cheng-Zhi
    Chen, Jia-Ling
    Wang, Zheng-Shuai
    Yang, Bin
    Wu, Xiao-Ming
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Defining Metabolic Rewiring in Lung Squamous Cell Carcinoma
    de Araujo, Rachel Paes
    Bertoni, Natalia
    Seneda, Ana L.
    Felix, Tainara F.
    Carvalho, Marcio
    Lewis, Keir E.
    Hasimoto, Erica N.
    Beckmann, Manfred
    Drigo, Sandra A.
    Reis, Patricia P.
    Mur, Luis A. J.
    METABOLITES, 2019, 9 (03)
  • [29] Lung squamous cell carcinoma combined with tuberculous pleurisy
    Zhang Yi
    Yao Shu-yang
    Li Yuan-bo
    Zhang Jian
    CHINESE MEDICAL JOURNAL, 2012, 125 (20) : 3755 - 3756
  • [30] Renal failure, paraproteinemia, and lung squamous cell carcinoma
    Safadi, R
    Gotsman, O
    Friedlaender, M
    Rubinger, D
    Popovtzer, M
    RENAL FAILURE, 1997, 19 (03) : 495 - 498